Tempest Therapeutics, Inc. (TPST) Operating cash flow 2016–2025
Tempest Therapeutics, Inc. (TPST) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$26.8MFY2025 · since FY2016: -$61.7M → -$26.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.8M | +18.8% |
| FY2024 | -$33.0M | -20.7% |
| FY2023 | -$27.4M | +12.0% |
| FY2022 | -$31.1M | -19.7% |
| FY2021 | -$26.0M | -36.5% |
| FY2020 | -$19.0M | +53.9% |
| FY2019 | -$41.2M | -74.3% |
| FY2018 | -$23.6M | -16.3% |
| FY2017 | -$20.3M | +67.1% |
| FY2016 | -$61.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice